Bacillus amyloliquefaciens GA1 as a source of potent antibiotics and other secondary metabolites for biocontrol of plant pathogens.

Microbial Cell Factories
Anthony Arguelles-AriasPatrick Fickers

Abstract

Phytopathogenic fungi affecting crop and post-harvested vegetables are a major threat to food production and food storage. To face these drawbacks, producers have become increasingly dependent on agrochemicals. However, intensive use of these compounds has led to the emergence of pathogen resistance and severe negative environmental impacts. There are also a number of plant diseases for which chemical solutions are ineffective or non-existent as well as an increasing demand by consumers for pesticide-free food. Thus, biological control through the use of natural antagonistic microorganisms has emerged as a promising alternative to chemical pesticides for more rational and safe crop management. The genome of the plant-associated B. amyloliquefaciens GA1 was sample sequenced. Several gene clusters involved in the synthesis of biocontrol agents were detected. Four gene clusters were shown to direct the synthesis of the cyclic lipopeptides surfactin, iturin A and fengycin as well as the iron-siderophore bacillibactin. Beside these non-ribosomaly synthetised peptides, three additional gene clusters directing the synthesis of the antibacterial polyketides macrolactin, bacillaene and difficidin were identified. Mass spectrometry analy...Continue Reading

References

May 1, 1976·Journal of General Microbiology·M Kenig, E P Abraham
Jan 1, 1987·Analytical Biochemistry·B Schwyn, J B Neilands
Feb 1, 1985·Journal of General Microbiology·H Chmara
Jun 16, 2000·Applied Microbiology and Biotechnology·I M BanatS S Cameotra
Mar 27, 2001·Biochimica Et Biophysica Acta·A YazganM A Marahiel
May 22, 2001·Environmental Microbiology·E Z Ron, E Rosenberg
Oct 10, 2001·Journal of Bacteriology·K TsugeM Shoda
Dec 6, 2003·International Journal of Systematic and Evolutionary Microbiology·Daniel R Zeigler
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Apr 23, 2004·Antonie van Leeuwenhoek·M LucyBernard R Glick
Jun 5, 2004·Biochemical and Biophysical Research Communications·Pooja Singh, Swaranjit Singh Cameotra
Nov 3, 2004·Environmental Pollution·Catherine N Mulligan
Jan 14, 2005·Critical Reviews in Microbiology·E SomersM Srinivasan
Apr 21, 2005·Critical Reviews in Microbiology·V H Tournas
Apr 28, 2005·Molecular Microbiology·Torsten Stein
Aug 5, 2005·Annual Review of Phytopathology·D R Fravel
Aug 9, 2005·Applied and Environmental Microbiology·Valérie LeclèrePhilippe Jacques
Nov 1, 1996·Applied and Environmental Microbiology·O Asaka, M Shoda
Oct 7, 2006·Molecular Plant-microbe Interactions : MPMI·UNKNOWN Prime-A-Plant GroupBrigitte Mauch-Mani
Apr 13, 2007·Molecular Plant-microbe Interactions : MPMI·Diego RomeroAlejandro Pérez-García
May 18, 2007·Annual Review of Microbiology·Thomas Danhorn, Clay Fuqua
Sep 12, 2007·Journal of Natural Products·Kathrin SchneiderRoderich D Süssmuth
Feb 22, 2008·Trends in Microbiology·Marc Ongena, Philippe Jacques
Jul 29, 2008·Research in Microbiology·Patrick FickersPhilippe Jacques
Apr 1, 1948·Proceedings of the Society for Experimental Biology and Medicine·M LANDY, G H WARREN
Feb 13, 2009·PloS One·Shalini PorwalVipin Chandra Kalia
Jun 25, 2009·Chemical Society Reviews·Jordan L Meier, Michael D Burkart
Jul 7, 2009·Annual Review of Microbiology·Ben Lugtenberg, Faina Kamilova

❮ Previous
Next ❯

Citations

Jun 1, 2012·Archives of Microbiology·Natalia MalfanovaMarc Ongena
Apr 29, 2010·Applied Microbiology and Biotechnology·Ibrahim M BanatRoger Marchant
Apr 30, 2011·Biotechnology Letters·Estibaliz Sansinenea, Aurelio Ortiz
Aug 18, 2012·Applied Biochemistry and Biotechnology·Atipan SaimmaiSuppasil Maneerat
Aug 1, 2012·Journal of the American Society for Mass Spectrometry·Khyati V PathakPadmanabhan Balaram
May 2, 2012·Microbial Cell Factories·Juana DiezAndreas Meyerhans
Dec 19, 2013·PloS One·Anthony Arguelles AriasPatrick Fickers
Jan 21, 2014·International Journal of Environmental Research and Public Health·Cuijuan ShiShanshan Guan
Aug 15, 2013·Marine Drugs·Muhammad Abdul Mojid MondolMohammad Tofazzal Islam
Apr 12, 2014·Applied Microbiology and Biotechnology·Jovana DeravelPhilippe Jacques
Jun 3, 2014·Microbial Cell Factories·Anil Kumar SinghSwaranjit Singh Cameotra
Sep 10, 2014·Standards in Genomic Sciences·Xiao-Yan LiuZi-Wen Yang
Jul 25, 2013·Journal of Chemical Ecology·Wilna J MoreePieter C Dorrestein
Jan 29, 2011·Critical Reviews in Microbiology·Vipin Chandra Kalia, Hemant J Purohit
Oct 30, 2013·Biotechnology and Applied Biochemistry·Khyati V PathakHaresh Keharia
Aug 21, 2013·Biotechnology Advances·Prasun KumarVipin C Kalia
Apr 11, 2015·Annals of Clinical Microbiology and Antimicrobials·Shine KadaikunnanRamzi Mothana
Apr 28, 2012·FEMS Microbiology Letters·Gabriele RiederSilja Wessler
Mar 7, 2013·Journal of Natural Products·Valeska Villegas-EscobarMagally Romero-Tabarez
Dec 6, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jen-Hung LiaoYung-Chang Liu
Nov 23, 2017·Microorganisms·Noor KhanAnn M Hirsch

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

BLAST
BLAST search
MUSCLE
PAUP
Vector NTI

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.